SCHEMBL4748432

SCHEMBL4748432

COc1ccc(C(C=O)c2cccc(Cl)c2Cl)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
NFKB1 P19838 1/20 0.40
PNMT P11086 1/20 0.40
ALDH1A1 P00352 3/20 0.39
LMNA P02545 1/20 0.39
GLA P06280 1/20 0.39
P2RX7 Q99572 3/20 0.38
NFE2L2 Q16236 3/20 0.38
RELA Q04206 1/20 0.38
KMT2A Q03164 1/20 0.37
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37
MAOB P27338 2/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CYP2A6 P11509 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9771536 0.77 IDO1 (0.50) CYP1A2CYP3A4CYP2D6NFKB1PNMT
SCHEMBL4775938 0.77 ALDH1A1 (0.52) CYP1A2CYP3A4CYP2D6ALDH1A1KMT2A
SCHEMBL5188701 0.77 MAPT (0.44) ALDH1A1LMNARELAKMT2AIDO1
SCHEMBL7456881 0.76 HPGD (0.50) CYP3A4CYP2D6NFKB1ALDH1A1LMNA
SCHEMBL11558512 0.76 ACP3 (0.44) CYP1A2CYP3A4CYP2D6ALDH1A1LMNA
SCHEMBL4970732 0.74 MAPT (0.36) CYP3A4ALDH1A1LMNAKMT2AMAOB
SCHEMBL1010013 0.74 HSP90AA1 (0.41) CYP1A2CYP3A4CYP2D6ALDH1A1KMT2A
SCHEMBL1515694 0.74 ACP3 (0.56) CYP1A2CYP3A4ALDH1A1LMNAKMT2A
SCHEMBL4746137 0.73 CYP1A2 (0.44) CYP1A2CYP3A4CYP2D6NFKB1PNMT
SCHEMBL7097655 0.72 NFE2L2 (0.44) CYP3A4ALDH1A1LMNANFE2L2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008123821-A1 4, 5-DIHYDRO-LH-IMIDAZOL-2-AMINE DERIVATIVES FOR USE IN THE TREATMENT OF RESPIRATORY, CARDIOVASCULAR, NEUROLOGICAL OR GASTROINTESTINAL DISORDERS ALBIREO AB (SE) 2008-10-16 WO disclosed